A detailed history of Sterling Capital Management LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Sterling Capital Management LLC holds 898 shares of IONS stock, worth $64,251. This represents 0.0% of its overall portfolio holdings.

Number of Shares
898
Previous 962 6.65%
Holding current value
$64,251
Previous $38 Million 54.56%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$39.94 - $65.42 $2,556 - $4,186
-64 Reduced 6.65%
898 $58.7 Million
Q2 2025

Aug 06, 2025

SELL
$25.51 - $40.0 $3,545 - $5,560
-139 Reduced 12.62%
962 $38 Million
Q1 2025

May 13, 2025

SELL
$30.17 - $34.97 $57,594 - $66,757
-1,909 Reduced 63.42%
1,101 $33.2 Million
Q4 2024

Feb 13, 2025

SELL
$33.73 - $40.36 $1,180 - $1,412
-35 Reduced 1.15%
3,010 $105 Million
Q3 2024

Nov 12, 2024

BUY
$40.06 - $51.86 $121,982 - $157,913
3,045 New
3,045 $122 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $10.2B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.